← Back to Search

Exercise Testing for Chronic Respiratory Disease (VTEP Trial)

N/A
Waitlist Available
Led By Arnaud CHAMBELLAN, MD
Research Sponsored by Lille Catholic University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 40 and over
Diagnosis of chronic obstructive pulmonary disease (GOLD II - IV) or pulmonary fibrosis (>6 months)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 19 days
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at two tests to measure exercise tolerance and muscle power in people with chronic respiratory disease.

Who is the study for?
This trial is for people over 40 with chronic respiratory diseases like moderate to severe COPD or pulmonary fibrosis. Participants must be able to follow verbal instructions and be covered by social security. It's not specified who can't join, but typically those with conditions affecting test performance would be excluded.
What is being tested?
The study is testing the validity of two exercise tolerance tests: the six minute Stepper Test (6MST) and the 5-repetition chair lift test (5STS), against established standards in patients with chronic respiratory disease.
What are the potential side effects?
Since this trial involves functional capacity tests rather than medications, side effects are minimal but may include muscle soreness or fatigue due to physical exertion during the exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 40 years old or older.
Select...
I have been diagnosed with severe lung disease for over 6 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~19 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 19 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Lower limb muscle power after Five Times Sit to Stand Test (5STS,) calculated by the ratio between STS mean velocity and STS mean force
Oxygen consumption
Secondary study objectives
Heart rate after 6MST
Leg fatigue after 6MST measured by the modified Borg scale
Lower limb muscle power after 5STS test
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients with a diagnosis of COPD (GOLD II- V) or pulmonary fibrosis (>6 months).Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Lille Catholic UniversityLead Sponsor
113 Previous Clinical Trials
31,535 Total Patients Enrolled
University of Lille Nord de FranceOTHER
12 Previous Clinical Trials
2,520 Total Patients Enrolled
Arnaud CHAMBELLAN, MDPrincipal InvestigatorHôpital Saint Philibert, GHICL
~14 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top